Kim, T.-Y.; Min, G.-J.; Jeon, Y.-W.; Yahng, S.-A.; Cho, S.-G.; Lee, J.-M.; Kim, M.; Eom, K.-S.
Inferior Outcomes of Fludarabine–Cyclophosphamide–Rituximab Chemotherapy in Korean Chronic Lymphocytic Leukemia Patients with Concurrent Thrombocytopenia and Anemia. Biomedicines 2025, 13, 194.
https://doi.org/10.3390/biomedicines13010194
AMA Style
Kim T-Y, Min G-J, Jeon Y-W, Yahng S-A, Cho S-G, Lee J-M, Kim M, Eom K-S.
Inferior Outcomes of Fludarabine–Cyclophosphamide–Rituximab Chemotherapy in Korean Chronic Lymphocytic Leukemia Patients with Concurrent Thrombocytopenia and Anemia. Biomedicines. 2025; 13(1):194.
https://doi.org/10.3390/biomedicines13010194
Chicago/Turabian Style
Kim, Tong-Yoon, Gi-June Min, Young-Woo Jeon, Seung-Ah Yahng, Seok-Goo Cho, Jong-Mi Lee, Myungshin Kim, and Ki-Seong Eom.
2025. "Inferior Outcomes of Fludarabine–Cyclophosphamide–Rituximab Chemotherapy in Korean Chronic Lymphocytic Leukemia Patients with Concurrent Thrombocytopenia and Anemia" Biomedicines 13, no. 1: 194.
https://doi.org/10.3390/biomedicines13010194
APA Style
Kim, T.-Y., Min, G.-J., Jeon, Y.-W., Yahng, S.-A., Cho, S.-G., Lee, J.-M., Kim, M., & Eom, K.-S.
(2025). Inferior Outcomes of Fludarabine–Cyclophosphamide–Rituximab Chemotherapy in Korean Chronic Lymphocytic Leukemia Patients with Concurrent Thrombocytopenia and Anemia. Biomedicines, 13(1), 194.
https://doi.org/10.3390/biomedicines13010194
